⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1717828 | 1.00 | HMGCR (0.41) | — | |
| Hydrochloric Acid SCHEMBL28883817 | 0.97 | HMGCR (0.39) | — | |
| Hydrochloric Acid SCHEMBL1092821 | 0.97 | HMGCR (0.39) | — | |
| Methane SCHEMBL27575418 | 0.97 | HMGCR (0.39) | — | |
| SCHEMBL17559271 | 0.97 | HMGCR (0.39) | — | |
| Acetic Acid SCHEMBL20839531 | 0.94 | CTH (0.42) | — | |
| SCHEMBL28060901 | 0.89 | DPP4 (0.35) | — | |
| Hydrogen Sulfide SCHEMBL27991575 | 0.87 | EGLN1 (0.37) | — | |
| SCHEMBL8654274 | 0.85 | DPP4 (0.33) | — | |
| SCHEMBL14805819 | 0.85 | EGLN1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 21329 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4218790-B1 | MODULATORS OF COMPLEMENT ACTIVITY | UCB HOLDINGS INC (US) | 2026-02-18 | — | — | EP | claimed |
| US-12552837-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | Bicyclerd Limited (GB) | 2026-02-17 | — | — | US | claimed |
| EP-4227300-B1 | TRUNCATED EVANS BLUE MODIFIED FIBROBLAST ACTIVATION PROTEIN INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | YANTAI LANNACHENG BIOTECHNOLOGY CO LTD (CN) | 2026-01-28 | — | — | EP | claimed |
| US-20260001910-A1 | PEPTIDES AND USES THEREOF | PREVECEUTICAL MEDICAL INC (CA) | 2026-01-01 | — | — | US | claimed |
| EP-4652183-A1 | PEPTIDE-DRUG CONJUGATES FOR TARGETED THERAPY OF RENAL DISEASES | Shanghai MicuRx Pharmaceutical Co., Ltd. (CN) | 2025-11-26 | — | — | EP | claimed |
| US-20250340595-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) | BICYCLETX LTD (GB) | 2025-11-06 | — | — | US | claimed |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | BICYCLE TX LTD (GB) | 2025-10-23 | — | — | US | claimed |
| WO-2025199636-A1 | TARGETED RADIOLIGAND COMPOUNDS AND USES THEREOF | MCMASTER UNIVERSITY (CA) | 2025-10-02 | — | — | WO | claimed |
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | claimed |
| US-20250276073-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) | BICYCLETX LIMITED (GB) | 2025-09-04 | — | — | US | claimed |
| EP-0455133-A2 | Peptide antagonists of bradykinin | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-11-06 | — | — | EP | claimed |
| US-4961873-A | Absorbent composition containing a severely-hindered amine mixture with amine salts and/or aminoacid additives for the absorption of H2 S | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1990-10-09 | — | — | US | claimed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | claimed |
| EP-0373549-A2 | Amino acid derivatives with enzyme-inhibiting properties, process to synthetise them, composition containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-20 | — | — | EP | claimed |
| EP-0372537-A2 | Urea derivatives of dipeptides with enzyme-inhibiting properties, process to make them, compositions containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-06-13 | — | — | EP | claimed |
| EP-0366385-A1 | Guanine derivatives having antiviral activity and their pharmaceutically acceptable salts | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-05-02 | — | — | EP | claimed |
| US-4895670-A | SELECTIVITY | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1990-01-23 | — | — | US | claimed |
| US-4892674-A | Addition of severely-hindered amine salts and/or aminoacids to non-hindered amine solutions for the absorption of H2 S | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1990-01-09 | — | — | US | claimed |
| EP-0303243-A2 | Use of atrial natriuretic factor (ANF), fragments and analogues thereof, for the treatment of cardiac disorders | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-15 | — | — | EP | claimed |
| EP-0299397-A2 | Peptides with vasorelaxing, natriuretic and diuretic activities, preparation process, agents containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-01-18 | — | — | EP | claimed |